A pipeline fungicide chemistry from Bayer offering 10 per cent better control of septoria is set to hit the market by 2022.
In Bayer trials, Iblon (isoflucypram) has shown 10 per cent better septoria control than existing SDHIs, and greater than 95 per cent control of yellow and brown rust.
Hailing it as the first, third generation SDHI, Will Charlton, fungicide campaign manager at Bayer said: “The key difference that makes it third generation is it has a unique cyclopropyl unit.
“This gives it greater flexibility than existing SDHIs, so it has the ability to bind to the site of the pathogen you are trying to control better.”
The product has also shown persistence in trials, added Mr Charlton.
“We have found this kind of disease control really hangs on and it is persistent in the crop.
“Often when you have fungicides with persistent characteristics you lose an element of curativity, and we don’t seem to be seeing that with this, so you get persistency without the drawback.”
Bayer is hoping for sales of Iblon to be approved by 2022.